INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Type 2 Diabetes & Insulin Resistance desk →

1,146 studies · page 36 of 48

2016 / Randomized controlled trial

In obese adults, daily breakfast did not alter weight change or resting metabolic rate versus morning fasting, but improved oral glucose tolerance test insulin response.

In the Bath Breakfast Project, 23 obese adults were randomly assigned to daily breakfast (≥700 kcal before 1100) or extended fasting (0 kcal until 1200) for 6 weeks under free-living conditions. Breakfast resulted in greater physical activity thermogenesis during the morning (difference: 188 kcal/d; 95% CI: 40, 335), but without a consistent effect over 24 hours. Energy intake was not significantly greater with breakfast (difference: 338 kcal/d; 95% CI: -313, 988). Body mass increased across both groups over time with no treatment effects on body composition or resting metabolic rate, while daily breakfast was associated with a reduced insulinemic response to an oral-glucose-tolerance test relative to an increase with fasting (P = 0.05).

Chowdhury EA, Richardson JD, Holman GD, et al. Am J Clin Nutr, 2016. PMID 26864365

2016 / Randomized crossover trial

Aged garlic extract did not improve endothelial function or insulin resistance in diabetes

A randomized crossover pilot trial evaluated 26 adults with type 2 diabetes who consumed 1,200 mg of aged garlic extract or placebo daily for 4 weeks. Supplementation had no significant effect on insulin resistance or metabolic measures. In addition, aged garlic extract did not significantly alter markers of endothelial function, oxidative stress, or vascular inflammation in this high-risk population.

Atkin M, Laight D, Cummings MH J Diabetes Complications, 2016. PMID 26954484

2016 / Randomized controlled trial

Flaxseed added to lifestyle modification improved liver markers in fatty liver disease

In an open-label trial with 50 adults having non-alcoholic fatty liver disease, participants received either lifestyle changes alone or with 30 grams daily of milled flaxseed for 12 weeks. Both groups improved, but flaxseed produced greater reductions in ALT (-11.12 vs -3.7 U/L), AST (-8.29 vs -4 U/L), GGT (-15.7 vs -2.62 U/L), fibrosis (-1.26 vs -0.77 kPa), and steatosis (-47 vs -15.45 dB/m). Body weight and insulin resistance also decreased more with flaxseed.

Yari Z, Rahimlou M, Eslamparast T, et al. Int J Food Sci Nutr, 2016. PMID 26983396

2016 / Randomized crossover trial

An evening meal of rye kernel bread improved next-morning glucose regulation, satiety hormones, and subjective appetite in healthy young adults.

In a randomized crossover study, healthy young adults consumed evening meals of whole grain rye kernel bread (RKB) or white wheat bread (WWB) as either a single meal or across three consecutive evenings. Compared to WWB, the RKB evening meal decreased blood glucose (0-120 min, P = 0.001), serum insulin response (0-120 min, P < 0.05), and fasting free fatty acids (P < 0.05) the next morning. RKB also increased plasma PYY (0-120 min, P < 0.001), GLP-1 (0-90 min, P < 0.05), fasting acetate and butyrate (P < 0.05), breath hydrogen excretion (P < 0.001), and improved subjective appetite ratings (P < 0.05). With the exception of serum CRP, length of priming did not significantly alter outcomes.

Sandberg JC, Björck IM, Nilsson AC PLoS One, 2016. PMID 26990559

2016 / Clinical trial

A very low-calorie diet induced diabetes remission lasting six months in responders

Thirty adults with type 2 diabetes followed an eight-week very low-calorie diet before returning to an isocaloric maintenance plan. Body weight dropped from 98.0 ± 2.6 to 83.8 ± 2.4 kg and remained stable at 84.7 ± 2.5 kg at six months. Fasting blood glucose normalized below 7 mmol/L in 12 participants after refeeding and in 13 participants at six months, accompanied by recovered first-phase insulin response.

Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Diabetes Care, 2016. PMID 27002059

2016 / Randomized placebo-controlled trial

A nutritional combination with rodent efficacy showed minimal metabolic benefit in human trials.

Researchers evaluated a four-ingredient nutritional mixture (GSK2890457) in rodent models and a six-week randomized trial with healthy participants and adults with type 2 diabetes. In diabetic participants taking liraglutide, the supplement did not lower weight and produced slight decreases in mean glucose and HbA1c compared to placebo. In those taking metformin, weight increased by 1.26%, while mean glucose and HbA1c were decreased slightly versus placebo.

Hodge RJ, Paulik MA, Walker A, et al. PLoS One, 2016. PMID 27093610

2016 / Double-blind, placebo-controlled, balanced crossover trial

A single dose of resveratrol acutely increased cerebral vasodilator responsiveness in older adults with type 2 diabetes, with 75 mg showing maximum benefit.

In a balanced crossover trial, 36 adults with type 2 diabetes consumed single doses of synthetic trans-resveratrol (0, 75, 150, and 300 mg) at weekly intervals. CVR to a hypercapnic stimulus was assessed by transcranial Doppler ultrasound before and 45 minutes after treatment. Resveratrol increased CVR in the middle cerebral arteries, with mean within-individual changes from placebo of 13.8 ± 3.5% for 75 mg (P = 0.001), 8.9 ± 3.5% for 150 mg (P = 0.016), and 13.7 ± 3.3% for 300 mg (P < 0.001). Only the 75 mg dose significantly increased CVR in the posterior cerebral arteries (13.2 ± 4.5%, P = 0.016).

Wong RH, Nealon RS, Scholey A, et al. Nutr Metab Cardiovasc Dis, 2016. PMID 27105868

2016 / Randomized, double-blind, placebo-controlled clinical trial

In patients with NAFLD, 12 weeks of ginger supplementation significantly reduced ALT, GGT, inflammatory cytokines, insulin resistance, and hepatic steatosis.

A randomized, double-blind, placebo-controlled pilot trial assigned 44 patients with NAFLD to receive either 2 grams per day of a ginger supplement or an identical placebo for 12 weeks, with both groups advised to follow a modified diet and physical activity program. Compared to placebo, ginger supplementation led to significant reductions in alanine aminotransferase, γ-glutamyl transferase, inflammatory cytokines, insulin resistance index, and hepatic steatosis grade. No significant effect was found on hepatic fibrosis or aspartate aminotransferase.

Rahimlou M, Yari Z, Hekmatdoost A, et al. Hepat Mon, 2016. PMID 27110262

2016 / Randomized controlled trial

Adding flaxseed to lifestyle advice reduced metabolic syndrome prevalence and insulin resistance

A randomized trial assigned 44 patients with metabolic syndrome to lifestyle advice alone or with 30 grams of milled flaxseed daily. Metabolic syndrome rates dropped by 82% in the flaxseed group compared to 50% in controls. The flaxseed group experienced greater reductions in insulin resistance (p < 0.001), body weight, waist circumference, and body mass index, although blood pressure showed no significant alterations.

Yari Z, Rahimlou M, Poustchi H, et al. Phytother Res, 2016. PMID 27151322

2016 / Randomized controlled trial

Acute morning and evening blue-enriched light exposure increased insulin resistance and reduced sleepiness in healthy adults.

Nineteen healthy adults completed a 4-day inpatient protocol under dim light conditions and were randomized to 3 hours of blue-enriched light exposure either 0.5 hours after waking (n=9) or 10.5 hours after waking (n=10) on Day 3, with Day 2 serving as baseline. In both groups, insulin total area, HOMA-IR, and HOMA-IR AUC were increased, and subjective sleepiness was reduced with blue-enriched light compared to dim light. The evening group, but not the morning group, exhibited a significantly higher peak glucose value during blue-enriched light exposure compared to dim light. There were no other significant differences between morning and evening groups in response to blue-enriched light.

Cheung IN, Zee PC, Shalman D, et al. PLoS One, 2016. PMID 27191727

2016 / Retrospective analysis of a dietary intervention study

Daily white button mushroom intake for 16 weeks improved select antioxidant and anti-inflammatory markers in adults with metabolic syndrome.

Researchers retrospectively analyzed data from 37 adults with metabolic syndrome who consumed 100 g of white button mushrooms daily for 16 weeks, followed by a one-month mushroom-free period. At 16 weeks, participants showed a doubling of serum ergothioneine, increases in ORAC and adiponectin, and significant decreases in carboxymethyllysine (CML) and methylglyoxal (MG). No changes were observed in 8-isoprostane, leptin, or measures of insulin resistance or glucose metabolism. The authors noted that well-controlled studies are needed to confirm these findings.

Calvo MS, Mehrotra A, Beelman RB, et al. Plant Foods Hum Nutr, 2016. PMID 27193019

2016 / Randomized controlled trial

Mycoprotein meals reduced ad libitum energy intake and postprandial insulin in overweight adults.

In two randomized controlled trials, 55 overweight and obese adults consumed test meals containing varying mycoprotein amounts (44 g, 88 g, or 132 g) or isoenergetic chicken. High mycoprotein decreased subsequent ad libitum energy intake by 10% (280 kJ / 67 kcal, P=0.009) relative to chicken. All mycoprotein meals reduced postprandial insulin concentrations (incremental AUC drops of 8%, 12%, and 21%, P=0.004), without altering glucose, GLP-1, PYY, or energy expenditure.

Bottin JH, Swann JR, Cropp E, et al. Br J Nutr, 2016. PMID 27198187

2016 / Randomized controlled trial

A brown rice-based vegan diet led to greater reductions in HbA1c levels compared to a conventional diabetic diet in Korean patients with type 2 diabetes.

Participants with type 2 diabetes were randomly assigned to follow either a vegan diet (n = 46) or a conventional diet recommended by the Korean Diabetes Association 2011 (n = 47) for 12 weeks. Both groups experienced significant reductions in HbA1c, but reductions were larger in the vegan group than in the conventional group (-0.5% vs. -0.2%; p-for-interaction = 0.017). Among participants with high compliance, the reduction difference between groups was larger (-0.9% vs. -0.3%), remaining significant after adjusting for changes in total energy intake or waist circumference. The authors noted that further studies are needed to evaluate the long-term effects of a vegan diet.

Lee YM, Kim SA, Lee IK, et al. PLoS One, 2016. PMID 27253526

2016 / Randomized controlled trial and animal study

Protein restriction and low branched-chain amino acid intake improved markers of metabolic health.

A randomized controlled trial in humans demonstrated that a moderate protein-restricted diet improved markers of metabolic health. In parallel animal experiments, mice provided a diet specifically low in branched-chain amino acids showed improvements in glucose tolerance and body composition comparable to whole protein restriction. These changes operated through distinct metabolic pathways, indicating that dietary amino acid composition directly influences metabolic function.

Fontana L, Cummings NE, Arriola Apelo SI, et al. Cell Rep, 2016. PMID 27346343

2016 / Intervention study (mice and humans)

Dietary protein dilution increases serum markers of metabolic health in mice and humans and improves glucose homeostasis in mice via an NEAA/NUPR1/FGF21 axis.

Investigators studied the effects of dietary protein dilution (DPD) on metabolic health markers in mice and humans, as well as its mechanistic pathways in murine models. DPD increased serum markers of metabolic health in both mice and humans. In lean mice, DPD promoted metabolic inefficiency by increasing carbohydrate and fat oxidation, and in murine models of obesity, it prevented and curtailed impaired glucose homeostasis independently of obesity and food intake. The metabolic improvements required liver-derived FGF21, induced by liver-integrated stress response-driven NUPR1 triggered by insufficiency of select nonessential amino acids.

Maida A, Zota A, Sjøberg KA, et al. J Clin Invest, 2016. PMID 27548521

2016 / Randomized controlled trial

Alternate-day fasting and daily caloric restriction produced similar 8-week weight loss in obesity.

A randomized pilot trial assigned 26 adults with obesity to 8 weeks of zero-calorie alternate-day fasting or daily calorie restriction (-400 kcal/day). Weight loss did not differ significantly between groups at 8 weeks (-8.2 ± 0.9 kg for fasting vs -7.1 ± 1.0 kg for restriction), nor were there differences in lipids, body composition, or insulin sensitivity. After 24 weeks of unsupervised follow-up, weight regain was similar between groups.

Catenacci VA, Pan Z, Ostendorf D, et al. Obesity (Silver Spring), 2016. PMID 27569118

2016 / Randomized controlled trial

Eating the main meal at lunch rather than dinner enhanced weight loss

In a 12-week trial of 80 overweight and obese women in a weight-loss program, 69 completed allocating their main energy intake to lunch or dinner. The lunch group achieved greater reductions in weight (-5.85 kg vs. -4.35 kg; P = 0.003), body mass index (P = 0.003), fasting insulin (P < 0.001), and insulin resistance (P = 0.001) than the dinner group. Fasting glucose and lipid profiles did not differ between groups.

Madjd A, Taylor MA, Delavari A, et al. Am J Clin Nutr, 2016. PMID 27581472

2016 / Clinical trial

Higher protein during weight loss prevented improvements in muscle insulin sensitivity in women.

A clinical trial examined postmenopausal women with obesity undergoing approximately 10% weight loss on hypocaloric diets containing either 0.8 g or 1.2 g protein/kg/day. The higher-protein diet reduced lean tissue loss by roughly 45%. However, higher protein intake also eliminated the weight-loss-induced gains in muscle insulin signaling and insulin-stimulated glucose uptake, while preventing cellular adaptations in oxidative stress pathways.

Smith GI, Yoshino J, Kelly SC, et al. Cell Rep, 2016. PMID 27732859

2016 / Comparative clinical trial

A very low-calorie diet and gastric bypass induced distinct systemic inflammatory changes

Systemic inflammation was assessed three months after gastric bypass (n=15) or a very low-calorie diet (n=12) in morbidly obese women with type 2 diabetes, plus 12 lean controls. Both interventions lowered CRP and leptin while raising adiponectin. However, the diet was linked to reductions in TNF-alpha, IL-2, and IL-6, whereas bypass was linked to increased TNF-alpha and higher numbers of activated cytotoxic T and B cells.

Lips MA, van Klinken JB, Pijl H, et al. Metabolism, 2016. PMID 27733249

2016 / Randomized crossover trial series

A short-term saturated fatty acid-enriched diet rapidly induced whole-body insulin resistance in subjects with normal and impaired glucose tolerance.

Researchers evaluated high-calorie diets enriched with saturated fatty acids (SFA) or carbohydrates (CARB) compared to a standard eucaloric AHA control diet in subjects with NGT or IGT. Steady state plasma glucose (SSPG) increased by 83±74% versus control after a 24-hour SFA diet across the entire cohort (n=38; NGT: 92±82%, n=22; IGT: 65±55%, n=16; all p<0.001) and by 55±32% after a single SFA breakfast (p=0.008, n=7). The SSPG elevation was 24±31% after an overnight fast (p=0.04, n=10) and further attenuated 24 hours after returning to the control diet (19±35%, p=0.09, n=11), while a 24-hour CARB diet did not significantly increase SSPG (26±50%, p=0.11, n=12).

Koska J, Ozias MK, Deer J, et al. Metabolism, 2016. PMID 27733250

2016 / Randomised crossover study

Walking for 10 minutes after each main meal lowered postprandial glycaemia more than walking 30 minutes once daily in adults with type 2 diabetes.

A randomised crossover study evaluated 41 adults with type 2 diabetes mellitus comparing advice to walk 30 minutes each day versus advice to walk 10 minutes after each main meal for 2-week periods. Postprandial glycaemia iAUC over 3 hours post-meal was significantly lower when walking after meals compared with a single daily walk (ratio of geometric means 0.88, 95% CI 0.78, 0.99). The improvement was especially marked after the evening meal (0.78, 95% CI 0.67, 0.91), when carbohydrate consumption was highest. One participant died during the 30-day washout period, an event not judged to be related to study participation.

Reynolds AN, Mann JI, Williams S, et al. Diabetologia, 2016. PMID 27747394

2016 / Open, parallel, randomized study

In patients with type 2 diabetes, a hypocaloric vegetarian diet combined with exercise improved physical fitness more than a conventional hypocaloric diet.

A 12-week open parallel randomized study compared a vegetarian diet to a conventional diet, both with the same caloric restriction (-500 kcal/day), alongside supervised aerobic exercise in 74 patients with type 2 diabetes. All meals were provided for the entire study duration. VO2max increased by 12% in the vegetarian group (p < 0.001) with no significant change in the conventional group (p = 0.667; group x time p = 0.004). Maximal performance (Watt max) increased by 21% in the vegetarian group (p < 0.001) but did not change in the conventional group (p = 0.334; group x time p = 0.048).

Veleba J, Matoulek M, Hill M, et al. Nutrients, 2016. PMID 27792174

2016 / Randomized, double-blind, placebo-controlled, crossover trial

Consuming kale at 7 g or 14 g with a high-carbohydrate meal suppressed postprandial plasma glucose increases in Japanese adults.

In a randomized, double-blind, placebo-controlled crossover trial, 42 Japanese subjects consumed placebo or kale-containing food (7 g active-L or 14 g active-H) with a high-carbohydrate meal. Maximum plasma glucose concentrations (Cmax) were significantly lower for active-L (163±24 mg/dl) and active-H (162±23 mg/dl) compared with placebo (176±26 mg/dl; P<0.01). Glucose AUC0-2 h was also significantly lower for active-L (268±43 mg/h/dl) and active-H (266±42 mg/h/dl) versus placebo (284±43 mg/h/dl; P<0.05). No significant differences were found in postprandial plasma insulin levels, and no adverse events were observed.

Kondo S, Suzuki A, Kurokawa M, et al. Biomed Rep, 2016. PMID 27882216

2016 / Randomized, double-blind, controlled clinical trial

Probiotic milk supplementation for 12 weeks improved cognitive function and several metabolic markers in patients with Alzheimer's disease.

Sixty patients with Alzheimer's disease were randomized to receive 200 ml/day of control milk or probiotic milk containing Lactobacillus acidophilus, L. casei, Bifidobacterium bifidum, and L. fermentum for 12 weeks. Compared to controls (-5.03% ± 3.00), the probiotic group showed a significant improvement in MMSE scores (+27.90% ± 8.07, P < 0.001). Probiotic intake also led to significant favorable changes in plasma malondialdehyde, serum hs-CRP, HOMA-IR, beta cell function, serum triglycerides, and QUICKI compared with control (all P < 0.01). No considerable effects were observed on fasting plasma glucose, other lipid profiles, or other biomarkers of oxidative stress and inflammation.

NANO counterpoint →

Akbari E, Asemi Z, Daneshvar Kakhaki R, et al. Front Aging Neurosci, 2016. PMID 27891089